These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16733508)

  • 41. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects.
    Mavrides E; Cobian-Sanchez F; Tekay A; Moscoso G; Campbell S; Thilaganathan B; Carvalho JS
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):106-10. PubMed ID: 11251916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
    Ghi T; Huggon IC; Zosmer N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
    Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
    Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simplified first-trimester fetal cardiac screening (four chamber view and ventricular outflow tracts) in a low-risk population.
    Orlandi E; Rossi C; Perino A; Musicò G; Orlandi F
    Prenat Diagn; 2014 Jun; 34(6):558-63. PubMed ID: 24585687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The examiner's ultrasound experience has a significant impact on the detection rate of congenital heart defects at the second-trimester fetal examination.
    Tegnander E; Eik-Nes SH
    Ultrasound Obstet Gynecol; 2006 Jul; 28(1):8-14. PubMed ID: 16736449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First trimester ultrasonography in screening and detection of fetal anomalies.
    Sonek J
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):45-61. PubMed ID: 17304542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The fetal heart or the lymphatic system or ...? The quest for the etiology of increased nuchal translucency.
    Carvalho JS
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):215-20. PubMed ID: 15736188
    [No Abstract]   [Full Text] [Related]  

  • 48. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performing a fetal anatomy scan at the time of first-trimester screening.
    Timor-Tritsch IE; Fuchs KM; Monteagudo A; D'alton ME
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):402-7. PubMed ID: 19155913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Search for hemodynamic compromise at 11-14 weeks in monochorionic twin pregnancy: is abnormal flow in the ductus venosus predictive of twin-twin transfusion syndrome?
    Matias A; Ramalho C; Montenegro N
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):79-86. PubMed ID: 16203591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for cardiac malformations detected by fetal echocardiography in a tertiary center.
    Perri T; Cohen-Sacher B; Hod M; Berant M; Meizner I; Bar J
    J Matern Fetal Neonatal Med; 2005 Feb; 17(2):123-8. PubMed ID: 16076619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal diagnosis of congenital heart disease.
    Gembruch U
    Prenat Diagn; 1997 Dec; 17(13):1283-98. PubMed ID: 9509546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of prenatal screening strategies for congenital heart disease.
    Pinto NM; Nelson R; Puchalski M; Metz TD; Smith KJ
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):50-7. PubMed ID: 24357432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac anatomy screening: what is the best time for screening in pregnancy?
    Allan LD
    Curr Opin Obstet Gynecol; 2003 Apr; 15(2):143-6. PubMed ID: 12634606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetal echocardiographic screening for congenital heart disease: the importance of the four-chamber view.
    Copel JA; Pilu G; Green J; Hobbins JC; Kleinman CS
    Am J Obstet Gynecol; 1987 Sep; 157(3):648-55. PubMed ID: 3631166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indications for fetal echocardiography high referral, low yield?
    Davey BT; Seubert DE; Phoon CK
    Obstet Gynecol Surv; 2009 Jun; 64(6):405-15. PubMed ID: 19445814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening of congenital heart disease in the second trimester of pregnancy: current knowledge and new perspectives to the clinical practice.
    Alves Rocha L; Araujo Júnior E; Rolo LC; Barros FS; Silva KP; Martinez LH; Nardozza LM; Moron AF
    Cardiol Young; 2014 Jun; 24(3):388-96. PubMed ID: 24229491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fetal imaging: Executive summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop.
    Reddy UM; Abuhamad AZ; Levine D; Saade GR;
    Am J Obstet Gynecol; 2014 May; 210(5):387-97. PubMed ID: 24793721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in fetal cardiac imaging.
    Sklansky M
    Pediatr Cardiol; 2004; 25(3):307-21. PubMed ID: 15360121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prenatal detection and management of congenital heart disease].
    Cloez JL; Droulle P
    Arch Pediatr; 2001 Oct; 8(10):1113-5. PubMed ID: 11683105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.